Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Phase 2 Trial Results: Weight Loss Outcomes in Type 2 Diabetes At the highest 12 mg dose, adults with type 2 diabetes achieved approximately 16.9% mean body weight reduction from baseline at 24 weeks in a randomised, placebo-controlled phase 2 trial published in The Lancet (2023)
GLP-1 Receptor Limb GLP-1R activation is the most extensively characterised pathway in this class
27-31 They are used as first-line agents in the management of proteinuria and hypertension (with or without diabetes)
BPC-157 is the supply line
However, if body aches are accompanied by dark urine, severe muscle weakness, high fever, or signs of an allergic reaction, contact your healthcare provider immediately
US$ 23.43
US$ 23.66
US$ 20.58
